Meeting the 2030 Target on Reducing the Global Burden of AMR: Pathways for Strengthening and Leveraging Surveillance in Developing Countries
By Prateek Sharma and Viviana Munoz Tellez
Antimicrobial Resistance (AMR) poses a major and growing threat to global health, yet low- and middle-income countries (LMICs) face significant challenges in implementing AMR surveillance –collection and analysis of data on AMR. Global AMR targets, including the United Nations’ goal of reducing AMR-associated deaths by 10 percent by 2030 and achieving diagnostic capacity in 80 percent of countries, rely on surveillance data that are often incomplete, hospital-centered, and unrepresentative of community infections in LMICs. While the Global Antimicrobial Resistance and Use Surveillance System (GLASS) of the World Health Organization (WHO) provides a standardized framework, in LMICs limited access to diagnostics, high laboratory costs, and reliance on data from specialized hospitals constrain participation and data comparability. Modeling studies have helped quantify the global burden of AMR, yet their reliance on sparse LMIC data underscores the need for improved primary surveillance. Achieving the United Nations’ 2030 target—where 80 per cent of countries can test resistance in all GLASS pathogens—will require substantial investment, technical support, and sustained political commitment. Embedding AMR surveillance within health systems and strengthening pandemic prevention and preparedness can help unlock external funding for eligible LMICs through the Pandemic Fund and the Global Fund.
Statement Delivered by the South Centre to the 79th World Health Assembly (WHA79)
Agenda Item 12.5 Primary Healthcare Agenda Item 12.8 Report of the Expert Advisory Group on the WHO Global Code of Practice on the International Recruitment of Health Personnel
Primary healthcare (PHC) is the backbone of Universal Health Coverage (UHC), health system resilience and the right to health. It is our first line of defense in emergencies and pandemics. Bold investment in PHC is overdue. Water, sanitation, and hygiene (WASH), the health workforce, integrated services and Antimicrobial Resistance (AMR) response cannot wait.
Statement by the South Centre on the Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement
Geneva, 18 May 2026
The South Centre welcomes the one-year extension to finalise the Pathogen Access and Benefit-Sharing (PABS) Annex.
Developing countries showed remarkable unity and put forward concrete proposals. Had these been the basis of work, negotiations could have concluded sooner. Now all Parties must rise to the moment and deliver an Annex that meaningfully advances equity in pandemic prevention, preparedness and response.
No Country Can Cruise Past Collective Responsibility: The Hantavirus Outbreak
By Dr. Viviana Munoz Tellez
The hantavirus outbreak aboard the MV Hondius is a vivid reminder of why global health cooperation matters. It is one of many simultaneous outbreaks WHO is responding to, at a time the broader architecture of global health is under growing strain. The WHO faces deep funding shortfalls as some governments retreat from multilateralism. Despite International Health Regulations strengthened in response to COVID-19 and a newly adopted Pandemic Agreement, the system for pathogen access and benefit sharing that it must contain remains unfinished. Every country’s health security depends on global collaboration and solidarity.
Towards an Operative Pathogen ABS System: Implementing the Equal Footing Requirement of Article 12 of the WHO Pandemic Agreement
By Viviana Munoz Tellez, Nirmalya Syam
Multilateral negotiations on the Pathogen Access and Benefit-Sharing (PABS) system remain deadlocked. As required by Article 12 of the World Health Organization (WHO) Pandemic Agreement, the annex operationalizing the PABS system must place on equal footing the rapid and timely sharing of PABS Materials and Sequence Information with the rapid, timely, fair and equitable sharing of benefits that arise from their sharing and utilization. The Annex cannot impose binding sharing obligations on State Parties while making it optional for users of PABS Materials to opt in to the PABS system voluntarily, without legally binding obligations on benefit sharing arising from the utilization of PABS Materials and Sequence Information. The Annex also cannot create a hybrid system providing alternative routes for access, either “open” or “restricted”. This would be inconsistent with Article 12 of the Pandemic Agreement and with the obligations of parties under the Convention on Biological Diversity and its Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization. The Annex must include a standardized contractual framework binding all actors in the PABS chain, a minimum manufacturer participation threshold before country obligations become active, and ensure benefit-sharing is not confined to pandemic emergencies.
The South Centre carries out multiple activities to support developing countries with policy-oriented research, inputs and advice for negotiations and capacity building. The Report summarizes the South Centre’s activities in 2025 and highlights the contexts in which they were conducted as well as the objectives that were pursued with their implementation.
South Centre Statement to IGWG5 on the WHO Pandemic Agreement
9 February 2026
The World Health Organization (WHO) Intergovernmental Working Group (IGWG) is reconvening to negotiate a Pathogen Access and Benefit Sharing (PABS) System to make operational Article 12 of the WHO Pandemic Agreement, concluded in May 2025 but requiring conclusion of the PABS to move towards ratifications. The Fifth Meeting of the IGWG (IGWG5) will meet from 9-14 February 2026, and the negotiations are meant to conclude by May 2026.
The South Centre has made a statement to the IGWG5 highlighting the imbalance in the current Bureau text. The statement of the South Centre is reproduced below.
30 Years supporting advancing multilateral rules for the fair and equitable sharing of the benefits arising from the utilization of biological diversity
By Dr. Viviana Munoz Tellez
South Centre 30th Anniversary Series No. 1, 7 January 2026
Countries are bound through international agreements to advance biodiversity conservation, including by maintaining genetic diversity, to ensure sustainable use of biodiversity and advance both access and fair and equitable sharing of benefits from the utilization of genetic resources and associated traditional knowledge. These obligations are also reasserted in the United Nations (UN) agreed Sustainable Development Goals (SDGs).
There are several international agreements in which these issues are addressed, including the Convention on Biological Diversity (CBD), the International Treaty on Plant Genetic Resources for Food and Agriculture (ITPGRFA Treaty), the Agreement under the UN Convention on the Law of the Sea on the Conservation and Sustainable Use of Marine Biological Diversity of Areas Beyond National Jurisdiction (BBNJ), as well as fora where these issues are debated or negotiated, such as those conducted under the auspices of the World Health Organization (WHO), the International Union for the Protection of New Varieties of Plants (UPOV), the World Intellectual Property Organization (WIPO), the United Nations Environment Programme (UNEP) and the World Trade Organization (WTO).
The South Centre has provided constant support over the years to developing countries in advancing their common interests in this field and ensuring coherence and synergies among the different conventions and negotiations.
Health Equity in Global Governance: growing recognition in need of concrete actions
By Carlos M. Correa
Health equity is a foundational principle of global health governance that should ensure all individuals have fair and just opportunities to achieve optimal health, regardless of social, economic, or geographical disparities. The right to health is recognized as a fundamental human right in Article 12 of the International Covenant on Economic, Social and Cultural Rights (ICESCR). This document explores the concept of health equity drawing on United Nations General Assembly (UNGA) resolutions and key instruments from the World Health Organization (WHO). It discusses the challenges and opportunities for developing countries in pursuing equitable health outcomes, including advancing sexual and reproductive health and rights.
Participation of South Centre Member Countries in the WHO GLASS: Progress and Gaps in AMR Surveillance and Stewardship Efforts
By Dr. Rasha Abdelsalam Elshenawy
This study highlights antimicrobial resistance (AMR) surveillance challenges in LMICs, focusing on the 55 South Centre Member States’ enrolment in the WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS). Despite progress since its 2016 launch, significant gaps persist: only 60 percent of South Centre Member States report AMR surveillance to GLASS, and just 38 percent report antimicrobial use (AMU) data to GLASS. The COVID-19 pandemic substantially disrupted surveillance activities, with rates declining from 2020-2021 compared to pre-COVID-19 pandemic levels. Digital infrastructure, such as mobile reporting tools, cloud-based systems, and interactive dashboards, offers significant opportunities to strengthen AMR surveillance in resource-limited settings. The study recommends a holistic and phased approach for South Centre Member States, including developing integrated national AMR action plans with realistic implementation timelines, investing in laboratory and workforce development, establishing interoperable digital infrastructure, and strengthening regional collaboration mechanisms. By systematically addressing core surveillance challenges while strategically incorporating digital innovations where appropriate, countries can develop resilient monitoring systems that support effective stewardship, protect national populations, and contribute to global health security by preserving antimicrobial effectiveness for future generations.
The GUIDE Framework for Evidence-based Antibiotic Prescribing
Strengthening Antimicrobial Stewardship for the Healthcare Workforce
By Dr. Rasha Abdelsalam Elshenawy
Antimicrobial resistance (AMR) poses a critical threat to global health security, with inappropriate antibiotic prescribing in hospitals driving the spread of resistant pathogens. This GUIDE Framework for Evidence-Based Antibiotic Prescribing provides a structured, five-step model designed to strengthen antimicrobial stewardship (AMS) and empower the healthcare workforce to make informed, proportionate prescribing decisions.
